
Sign up to save your podcasts
Or


Prof Rebecca A Dent from National Cancer Centre Singapore, Dr Hans Lee from Sara Cannon Research Institute in Nashville, Tennessee, Dr Neel Pasricha from the University of California, San Francisco, and Dr Tiffany A Richards from The University of Texas MD Anderson Cancer Center in Houston, discuss strategies to manage ocular toxicities associated with antibody-drug conjugates and other cancer therapies.
CME information and select publications here.
By Dr. Neil Love4.4
6262 ratings
Prof Rebecca A Dent from National Cancer Centre Singapore, Dr Hans Lee from Sara Cannon Research Institute in Nashville, Tennessee, Dr Neel Pasricha from the University of California, San Francisco, and Dr Tiffany A Richards from The University of Texas MD Anderson Cancer Center in Houston, discuss strategies to manage ocular toxicities associated with antibody-drug conjugates and other cancer therapies.
CME information and select publications here.

135 Listeners

321 Listeners

495 Listeners

31 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

57 Listeners

290 Listeners

3,333 Listeners

197 Listeners

513 Listeners

57 Listeners

189 Listeners

0 Listeners